ADB-BUTINACA

ADB-BUTINACA (also known as ADMB-BINACA using EMCDDA naming standards^[3]) is a synthetic cannabinoid compound which has been sold as a designer drug.^{[4][5][6][7][8]} It is a potent CB₁ agonist, with a binding affinity of 0.29nM for CB1 and 0.91nM for CB2, and an EC₅₀ of 6.36 nM for CB1.^{[9][10][11][12][13][14][15]}

Legal status

• BR: Class F2 (Prohibited psychotropics)^[1]
• CA: Schedule II
• DE: BtMG Anlage II
• UK: Class B
• US: Schedule I
• UN: Psychotropic Schedule II^[2]

CAS Number

• 2682867-55-4 ^Y

PubChem CID

• 155907792

ChemSpider

• 81407832

Quick facts Legal status, Identifiers ...

ADB-BUTINACA

Legal status
Legal status	BR: Class F2 (Prohibited psychotropics)[1] CA: Schedule II DE: BtMG Anlage II UK: Class B US: Schedule I UN: Psychotropic Schedule II[2]
Identifiers
IUPAC name N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3-carboxamide
CAS Number	2682867-55-4 Y
PubChem CID	155907792
ChemSpider	81407832
UNII	ZJ6LS4NVM9
ChEMBL	ChEMBL5169682
CompTox Dashboard (EPA)	DTXSID501342361
Chemical and physical data
Formula	C18H26N4O2
Molar mass	330.432 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(N[C@H](C(N)=O)C(C)(C)C)C1=NN(CCCC)C2=C1C=CC=C2
InChI InChI=1S/C18H26N4O2/c1-5-6-11-22-13-10-8-7-9-12(13)14(21-22)17(24)20-15(16(19)23)18(2,3)4/h7-10,15H,5-6,11H2,1-4H3,(H2,19,23)(H,20,24)/t15-/m1/s1 Key:GPWADXHYJAZPAX-OAHLLOKOSA-N

Close